What changed in this filing

/stocks — the workspaceLOADING

Item 2. Unregistered Sales of Equity Securities

2020-10-22 compared with 2020-08-13 · 28 added, 36 removed, 4 unchanged (94% of the section changed)

Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities

Unregistered Sales

On May 2, 2019, the

Sponsor paid $25,000, or approximately $0.002 per share, on behalf of the Company in exchange for a capital contribution and in

consideration of 11,500,000 shares of Class B common stock, par value $0.0001 per share.

Such securities were issued in connection

with the Company’s organization pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities

Act of 1933, as amended (the “Securities Act”).

May 2, 2019, the Sponsor paid $25,000, or approximately $0.002 per share, on our behalf in exchange for a capital contribution

and in consideration of 11,500,000 shares of Class B common stock, par value $0.0001 per share.

Such securities were issued in

connection with the Company’s organization pursuant to the exemption from registration contained in Section 4(a)(2) of the

Securities Act of 1933, as amended (the “Securities Act”).

On September 3, 2019, the remainder of the underwriters’

over-allotment

option expired and the Sponsor forfeited 250,000 Founder Shares.

As of June 30, 2020, there were 11,250,000 shares of Class B common

stock outstanding.

On July 22, 2019, the

Sponsor purchased 7,333,333 Private Placement Warrants, each exercisable to purchase one share of Class A common stock at $11.50

per share, at a price of $1.50 per warrant ($11,000,000 in the aggregate), in a private placement that closed simultaneously with

the closing of the Initial Public Offering.

This issuance was made pursuant to the exemption from registration contained in Section

4(a)(2) of the Securities Act.

No underwriting discounts

or commissions were paid with respect to such sales.

Use of Proceeds

In connection with

the Initial Public Offering, we incurred offering costs of approximately $25.36 million (including underwriting commissions of

approximately $9.0 million and deferred underwriting commissions of approximately $15.75 million).

Other incurred offering costs

consisted principally preparation fees related to the Initial Public Offering.

After deducting the underwriting discounts and commissions

(excluding the deferred portion, which amount will be payable upon consummation of the Initial Business Combination, if consummated)

and the Initial Public Offering expenses, $450 million of the net proceeds from our Initial Public Offering and certain of the

proceeds from the private placement of the Private Placement Warrants (or $10.00 per Unit sold in the Initial Public Offering)

was placed in the Trust Account.

The net proceeds of the Initial Public Offering and certain proceeds from the sale of the Private

Placement Warrants are held in the Trust Account and invested as described elsewhere in this Quarterly Report on Form 10-Q.

There has been no material

change in the planned use of the proceeds from the Initial Public Offering and Private Placement as is described in the Company’s

final prospectus related to the Initial Public Offering.

over-allotment option expired and the Sponsor forfeited 250,000 Founder Shares.

As of September 30, 2020, there were 11,250,000

shares of Class B common stock outstanding.

July 22, 2019, the Sponsor purchased 7,333,333 Private Placement Warrants, each exercisable to purchase one share of Class A common

stock at $11.50 per share, at a price of $1.50 per warrant ($11,000,000 in the aggregate), in a private placement that closed

simultaneously with the closing of the Initial Public Offering.

This issuance was made pursuant to the exemption from registration

contained in Section 4(a)(2) of the Securities Act.

underwriting discounts or commissions were paid with respect to such sales.

connection with the Initial Public Offering, we incurred offering costs of approximately $25.36 million (including underwriting

commissions of approximately $9.0 million and deferred underwriting commissions of approximately $15.75 million).

Other incurred

offering costs consisted principally preparation fees related to the Initial Public Offering.

After deducting the underwriting

discounts and commissions (excluding the deferred portion, which amount will be payable upon consummation of the Initial Business

Combination, if consummated) and the Initial Public Offering expenses, $450 million of the net proceeds from our Initial Public

Offering and certain of the proceeds from the private placement of the Private Placement Warrants (or $10.00 per Unit sold in

the Initial Public Offering) was placed in the Trust Account.

The net proceeds of the Initial Public Offering and certain proceeds

from the sale of the Private Placement Warrants are held in the Trust Account and invested as described elsewhere in this Quarterly

Report on Form 10-Q.

has been no material change in the planned use of the proceeds from the Initial Public Offering and Private Placement as is described

in the Company’s final prospectus related to the Initial Public Offering.

Defaults Upon Senior Securities

Mine Safety Disclosures

Not applicable.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 2. Unregistered Sales of Equity Securities